L-carnitine transports fatty acids into the mitochondria, the furnaces of the cells, where energy can be obtained from the fatty acids
Or, the glutamate can be further converted to GABA using the GAD1 enzyme, which requires the active form of vitamin B6 (P5P) as a cofactor.[ref] Genetic variants that reduce the conversion of B6 to its active form, P5P, could therefore impact GABA synthesis and GABAergic neurons
Common community options include adding cagrilintide for satiety, adding MOTS-c for mitochondrial support, or adding a GH secretagogue (covered in the Advanced Recomp Stack) for lean mass
Framed for research, not as a safety guarantee
Despite these extensive and promising neuroprotective effects, Ruts journey to clinical application faces some challenges, such as its relatively low bioavailability, chemically unstable under certain conditions, including light, heat, and pH, pharmacokinetic limitations, interact with other medication could either reduce Ruts effectiveness or increase the risk of adverse effects and its safety profile with long-term use or at high doses (Ozkan et al
